Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma

• المؤلفون الرئيسيون: Xiaoming Bai (مؤلف), Dan Xiang (مؤلف), Mengxi Huang (مؤلف), Yitian Chen (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2024-06-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

FH-deficient Renal Cell Carcinoma (FH-deficient RCC) are inherited tumors caused by mutations in the fumarate hydratase (FH) gene, which plays a role in the tricarboxylic acid cycle. These mutations often result in aggressive forms of renal cell carcinoma (RCC) and other tumors. Here, we present a c...